Evaluation de la Calidad de Vida en Pacientes con Linfoma no Hodgkin y Cancer Colo-Rectal en Diferentes Etapas Clinicas Atendidos en el Instituto Mexicano del Seguro Social

摘要

Introduction. In Mexico during 2008, were reported 127,604 new cancer cases, 6,347 of them were colorectal cancer cases and 4,276 Non-Hodgkin Lymphoma (NHL) cases. Objective. To Evaluate Health Related Quality of Life in Non-Hodgkin Lymphoma and colorectal cancer cases in different clinical stages, attended in a High Specialty Medical facility at the Instituto Mexicano del Seguro Social, during a 13 month period. Results. 162 patients were included, 56.8% (n=92) with NHL and 43.2% (n=70) with colorectal cancer. The scores obtained in the NHL group were: Global health status/QoL: 67.75 (±27.55), physical functioning 69.64 (±29.98), role functioning 71.38 (±33.73), emotional functioning 69.7 (±26.57), cognitive functioning 75.36 (±28.01), social functioning 79.35 (±29.38), fatigue 35.27 (±28.27), nausea and vomiting 13.41 (±21.85), pain 28.08 (±30.25), dyspnea 19.20 (±32.11), insomnia 30.80 (±38.03), appetite lost 26.45 (±36.16), constipation 19.20 (±32.11), diarrhea 12.32 (±26.48), financial difficulties 26.09 (±35.57). In colorec-tal cancer patients the scores were: Global health status/QpL: 68.21 (±24.46), physical functioning 67.38 (±30.45), role functioning 65.48 (±35.70), emotional functioning 66.43 (±26.84), cognitive functioning 78.57 (±26.49), social functioning 75.24 (±31.05), fatigue 37.78 (±31.62), nausea and vomiting 20.00 (±28.32), pain 37.38 (±34.45), dyspnea 11.90 (±26.64), insomnia 28.09 (±35.73), appetite lost 23.81 (±36.40), constipation 19.05 (±32.88), diarrhea 20.95 (±31.17), financial difficulties 34.76 (±38.67). Conclusions. With these basal results is important a follow-up with special attention to the treatment and attendance processes, in patients with this neoplasms and their impact on the quality of life.Palabras Claues: colo-rectal cancer, lymphoma, non-Hodgkin QLQ-C30, process of attendance, quality of life.